homogentisate 1,2-dioxygenase
Zuletzt aktualisiert 10. März 2025
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The HGD gene provides instructions for making an enzyme called homogentisate 1,2-dioxygenase, which is active mainly in the liver and kidneys. This enzyme participates in a multi step process that breaks down two protein building blocks (amino acids), phenylalanine and tyrosine. They get broken down when they are no longer needed or when there are too many of them. These two amino acids also play a role in making certain brain chemicals (neurotransmitters), hormones, and pigments.
Normal function
The HGD gene provides instructions for making an enzyme called homogentisate 1,2-dioxygenase, which is active mainly in the liver and kidneys. This enzyme participates in a multi step process that breaks down two protein building blocks (amino acids), phenylalanine and tyrosine. They get broken down when they are no longer needed or when there are too many of them. These two amino acids also play a role in making certain brain chemicals (neurotransmitters), hormones, and pigments.
Homogentisate 1,2-dioxygenase is responsible for a specific step in the breakdown of phenylalanine and tyrosine. Previous steps convert the two amino acids into a molecule called homogentisic acid. Homogentisate 1,2-dioxygenase adds two oxygen atoms to homogentisic acid, converting it to another molecule called maleylacetoacetate. Other enzymes break down maleylacetoacetate into smaller molecules that are later used for energy or to make other products that can be used by the body.
Conditions referring to this gene or chromosome
Other names
AKU
HGD_HUMAN
HGO
homogentisate 1,2-dioxygenase (homogentisate oxidase)
Homogentisic acid oxidase
homogentisicase
Related patient information and medicines

Patient information leaflet
Diabetische Nierenerkrankung
Diabetische Nierenerkrankung is a complication das occurs in some people with diabetes. Also, it aims to reduce the risk of developing cardiovascular diseases such as heart attack and stroke which are much more common than average in people with this disease. Diabetic kidney disease (diabetic nephropathy) is a complication that occurs in some people.

Patient information leaflet
Reisen zu abgelegenen Orten
Ensure your personal safety Remote travel involves a degree of risk over and above that of a 'normal' trip. Before travelling, consult the Foreign and Commonwealth Office (FCO) website (see under 'Further Reading and References' below) for advice on travelling to your destination. In addition to political problems, there may be hostility towards.

Patient information leaflet
Sichelzellenmerkmal
If you inherit a gene from one of your parents, called a sickle cell gene, you have a condition called sickle cell trait. If you inherit a sickle cell gene from both parents, you get a double dose of the sickle cell gene. This causes a condition called sickle cell disease (SCD). What is sickle cell trait. Sickle cell trait means having one gene.

Patient information leaflet
Pfeiffersches Drüsenfieber
Glandular fever (also known as infectious mononucleosis) is a viral infection that most often affects teenagers and young adults. Although it can make some people feel quite ill, full recovery is usual. What is glandular fever. Glandular fever is a viral infection, mostly caused by the Epstein-Barr virus. The virus can be passed from person to.

Patient information leaflet
Krebsstadien
If left untreated, Krebserkrankungen often go through three stages: local growth, spread to lymph channels and spread to other areas of the body. What do we mean by the term stages of cancer. The stage of a cancer is a measure of how much the cancer has grown and spread. Some cancers are also graded by looking at features of the cancer cells, using a.

Patient information leaflet
Vorhofflimmern und Schlaganfallprävention
Der Medikamenten used to prevent a atrial fibrillation-related stroke are called anticoagulants. These help to stop blood clots forming in your blood vessels. Why does atrial fibrillation increase your risk of having a stroke. The main complication of atrial fibrillation (AF) Atrial fibrillation is an increased risk of having a stroke Stroke. AF can.
Weiterführende Lektüre und Referenzen
- homogentisate 1,2-dioxygenase; MedlinePlus, National Library of Medicine.
- Amaya AA, Brzezinski KT, Farrington N, Moran GR. Kinetic analysis of human homogentisate 1,2-dioxygenase. Arch Biochem Biophys. 2004 Jan 1;421(1):135-42. doi: 10.1016/j.abb.2003.10.014.
- Bernardini G, Braconi D, Zatkova A, Sireau N, Kujawa MJ, Introne WJ, Spiga O, Geminiani M, Gallagher JA, Ranganath LR, Santucci A. Alkaptonuria. Nat Rev Dis Primers. 2024 Mar 7;10(1):16. doi: 10.1038/s41572-024-00498-x.
- Goicoechea De Jorge E, Lorda I, Gallardo ME, Perez B, Perez De Ferran C, Mendoza H, Rodriguez De Cordoba S. Alkaptonuria in the Dominican Republic: identification of the founder AKU mutation and further evidence of mutation hot spots in the HGO gene. J Med Genet. 2002 Jul;39(7):E40. doi: 10.1136/jmg.39.7.e40. No abstract available.
- Introne WJ, Perry M, Chen M. Alkaptonuria. 2003 May 9 [updated 2021 Jun 10]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1454/
- Rodriguez JM, Timm DE, Titus GP, Beltran-Valero De Bernabe D, Criado O, Mueller HA, Rodriguez De Cordoba S, Penalva MA. Structural and functional analysis of mutations in alkaptonuria. Hum Mol Genet. 2000 Sep 22;9(15):2341-50. doi: 10.1093/oxfordjournals.hmg.a018927.
- Srsen S, Muller CR, Fregin A, Srsnova K. Alkaptonuria in Slovakia: thirty-two years of research on phenotype and genotype. Mol Genet Metab. 2002 Apr;75(4):353-9. doi: 10.1016/S1096-7192(02)00002-1.
- Zatkova A, Chmelikova A, Polakova H, Ferakova E, Kadasi L. Rapid detection methods for five HGO gene mutations causing alkaptonuria. Clin Genet. 2003 Feb;63(2):145-9. doi: 10.1034/j.1399-0004.2003.00027.x.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
10. März 2025 | Neueste Version
1 Mar 2025 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

